Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas. - Wikidata - awgldk - TriplyDB

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

http://www.wikidata.org/entity/Q34493921

about

Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity Harnessing the power of Vδ2 cells in cancer immunotherapy γδ T cells in cancer immunotherapy Different maturation cocktails provide dendritic cells with different chemoattractive properties.Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Plasticity of γδ T Cells: Impact on the Anti-Tumor Response Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.γδ T cells and their potential for immunotherapy.Human γδT-cell subsets and their involvement in tumor immunity.The tumor microenvironment: a pitch for multiple players.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Adoptive immunotherapy of metastatic breast cancer: present and future.Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field?γδ T cells as a potential tool in colon cancer immunotherapy.Human gamma delta T regulatory cells in cancer: fact or fiction?Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment.γδ T cell-based anticancer immunotherapy: progress and possibilities.Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes.γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells.Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.Initiative action of tumor-associated macrophage during tumor metastasis.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.γδ T Cells: Unexpected Regulators of Cancer Development and Progression.Human αβ and γδ T Cells in Skin Immunity and Disease.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.

P2860

Q26745444-94605752-9EA4-43B7-869A-CF5BDA4C5F24 Q26782520-1B207AA3-9173-4432-B4E8-D50EEBD0470F Q27027547-3A211377-B750-449B-9064-0347479102BC Q28068988-83C32ED4-2BBF-4420-B190-E33A74C764FF Q30315866-51672A09-66F3-4178-9656-3C92C5BA5244 Q33855566-95BD17E3-4147-447E-A0B9-7B24DE5D1E26 Q34652408-2DCC0764-C95C-426B-A5BB-AE3731EC2972 Q35935862-6D009B8B-21DC-4414-8505-B2DAC70A573C Q37576001-3153A54B-E65D-4B02-9AD7-3637F9657949 Q37714642-031B8976-DA49-425F-BE50-CDC36675421F Q38101567-FA6CCCDB-F4C1-4ED1-BE3B-0216C2B9E354 Q38151057-82DFD020-2FF0-4D43-87DC-64C9932A0397 Q38171325-968F95A8-2BEC-4A83-8A3A-8C3A49F541EC Q38217512-34455828-A31F-48A9-976F-E699B43208BA Q38262257-EB30865E-7ACA-4292-B29A-7D308D61CEAC Q38283534-C6755BBE-FCB0-4275-ABD8-79D8EF6E0F89 Q38287973-FFFFECBF-BCB8-4240-9847-26FACC30465C Q38633738-CF03BF2E-FF2A-4E47-BAB7-19AF870BDFE3 Q38787725-A9FE7E27-44A2-440B-BC07-B78F57234D7C Q38848219-FD2E73D9-896E-488A-8C4A-0A2AD1FB9D61 Q38986536-9D858CA8-DA08-4FA8-B5ED-ACE2EAE4259D Q40213985-BAB3C298-ADB7-4E24-8AB9-0D18DD213CDE Q40724889-A6ED08FD-E79A-48C1-A922-F44AFD853FFB Q41057828-89CC112E-58F2-4574-A111-B9637F268CC5 Q47146669-14F026A9-770B-40E2-801E-A9E32112F8B0 Q50144881-E02B2129-9F1D-4F1B-A830-05B058A064D4 Q50420977-858D0A2B-1EC2-40A6-AA68-3F2D3EC81323 Q50581496-31E311A6-9943-49C7-A053-534853DD3477 Q52694263-6D8A7F0D-48B4-4A40-8CCD-D6A1CC1512B2 Q52731753-30A8410E-D18B-4CE9-8362-CA887E5D35AC Q54326921-F12A1AD8-0CC1-464C-8C8C-05A2349D6E89 Q55265385-422C5D8F-9A2D-485B-B196-A75D9FF5ED5E Q55311835-DC7832F5-CEF2-4AE0-B465-42A115B32F46

P2860

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

http://www.wikidata.org/entity/Q34493921

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@ast

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@en

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@nl

type

label

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@ast

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@en

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@nl

prefLabel

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@ast

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@en

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@nl

P1433

Q34493921-4F71778C-CD12-41D4-99FC-50587FD868D7

P1476

Q34493921-8FE18C1A-83D3-492E-A8FE-3AE8B982D3E9

P2093

Q34493921-09314815-185E-4C5F-BB87-9B913434CF3E

Q34493921-1E4FBB58-B975-48E9-B0A2-42218CCD6A50

Q34493921-36886784-184F-41EF-B024-BAC5DDD294E8

Q34493921-409A80C9-3E7F-4A7E-9349-E56E759BA757

Q34493921-9A078C27-B103-4B41-87C6-B344E6B2FD77

Q34493921-A07850C7-D24C-4065-BE39-9C2A91282A18

Q34493921-C9885925-9431-48BE-B4E9-ABF97854977A

Q34493921-D5C7C5DB-5107-4741-92EA-73AEFBACB67A

Q34493921-E87C61F6-210E-4D50-814D-C0886F9FA81D

P2860

Q34493921-06C85E70-9CF0-4C57-9EEE-DB691D15858F

Q34493921-0DF627F5-353A-4C54-8587-81AF94D896CC

Q34493921-0FD2ADCB-7078-4140-8C0C-DC2BE54543B9

Q34493921-1307184E-303D-4A01-859D-3C16BE1C869E

Q34493921-1AD9B857-C666-42D0-82B8-0CBCE3571B2C

Q34493921-1CDDCFD2-DC75-474F-A15D-AE6F42AB4853

Q34493921-1E83ECDA-222A-4B5D-AC82-738A86187E80

Q34493921-1E8BB0E3-F733-4FC9-BFE3-3A2B5CF325A9

Q34493921-22D0F084-7300-45E6-B424-FFD30351C460

Q34493921-2F37F2A9-2CAB-4B17-974D-2C780811A971

P304

Q34493921-D7F81328-84AD-4C8C-9547-D4EC1D443200

P31

Q34493921-593F13BD-8442-4C65-ADF6-9E27706803F3

P356

Q34493921-4342663A-870E-44B7-9A52-6A0276EC5976

P407

Q34493921-1BF2AB50-E0A0-4E58-AC04-23D13F5E9EF0

P433

Q34493921-49D473C2-B01F-45D7-96AD-041D753B072C

P478

Q34493921-50E2184A-06F1-4E76-AE6C-1A105975FF7A

P50

Q34493921-49A36B89-BCF3-4C64-B876-319ED4EB63BA

Q34493921-4A99A78A-3370-41BC-8663-6E39A774B5CA

Q34493921-72D0CFC3-73D9-493A-BAE7-E7747AA563FD

Q34493921-AF66DB21-C110-4A90-80FE-4C8947E8C1CB

Q34493921-CE38DCA3-671C-40B9-8746-83E063259A95

P577

Q34493921-E687BE51-DCDF-4B95-A0C3-DAAB3DEDF747

P5875

Q34493921-A011E3A5-6F42-4B09-87E0-2CAEBD8CA8CD

P698

Q34493921-78E9E52B-4868-4BEE-8478-4DA5B97082DE

P932

Q34493921-5C1C6F0D-0D38-4F5A-97AB-906681B0C394

P356

JOURNAL.PONE.0049878

P1433

P1476

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

@en

P2093

Carmela La Mendola

http://www.w3.org/2001/XMLSchema#string

Francesco Moschella

http://www.w3.org/2001/XMLSchema#string

Gaetana Rinaldi

http://www.w3.org/2001/XMLSchema#string

Giorgio Stassi

http://www.w3.org/2001/XMLSchema#string

Leonardo Zichichi

http://www.w3.org/2001/XMLSchema#string

Matilde Todaro

http://www.w3.org/2001/XMLSchema#string

Paolo Li Donni

http://www.w3.org/2001/XMLSchema#string

Serena Meraviglia

http://www.w3.org/2001/XMLSchema#string

Valentina Orlando

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Cancer immunotherapy: moving beyond current vaccines

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Microbial isoprenoid biosynthesis and human gammadelta T cell activation

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Final version of 2009 AJCC melanoma staging and classification

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

P304

e49878

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0049878

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Dieli

Adriana Cordova

Giuseppe Cicero

P577

2012-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233789865

http://www.w3.org/2001/XMLSchema#string

P698

23189169

http://www.w3.org/2001/XMLSchema#string

P932

3506540

http://www.w3.org/2001/XMLSchema#string